Home › Stocks › RIGL › All Fund Holders
RIGL — RIGEL PHARMACEUTICALS INC · All Fund Holders
Funds holding (latest): 37 · Reported value held: $273.89M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q2 2026 | 1.94M | $75.89M | 0.00% | Add |
| Vanguard Group history | Q4 2025 | 1.04M | $44.48M | 0.00% | Hold |
| D. E. Shaw & Co history | Q2 2026 | 542.54K | $21.22M | 0.01% | Add |
| Geode Capital Management history | Q2 2026 | 483.18K | $18.91M | 0.00% | Add |
| Marshall Wace history | Q2 2026 | 367.39K | $14.37M | 0.01% | Reduce |
| Goldman Sachs Group history | Q2 2026 | 226.78K | $8.87M | 0.00% | Reduce |
| Two Sigma Investments history | Q2 2026 | 207.58K | $8.12M | 0.01% | Reduce |
| Morgan Stanley history | Q2 2026 | 186.05K | $7.28M | 0.00% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 154.63K | $6.05M | 0.00% | Reduce |
| Northern Trust Corp history | Q2 2026 | 146.38K | $5.73M | 0.00% | Add |
| Renaissance Technologies history | Q2 2026 | 145.85K | $5.71M | 0.01% | Reduce |
| AQR Capital Management history | Q2 2026 | 124.80K | $4.88M | 0.00% | Add |
| Bank of America Corp history | Q2 2026 | 123.51K | $4.83M | 0.00% | Reduce |
| Franklin Resources history | Q2 2026 | 123.36K | $4.83M | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 122.95K | $4.81M | 0.00% | Add |
| Arrowstreet Capital history | Q1 2026 | 167.34K | $4.52M | 0.00% | Reduce |
| BNY Mellon history | Q2 2026 | 108.21K | $4.23M | 0.00% | Add |
| Fidelity Management & Research (FMR) history | Q2 2026 | 96.11K | $3.76M | 0.00% | Add |
| Janus Henderson Group history | Q1 2026 | 135.88K | $3.67M | 0.00% | Add |
| Millennium Management history | Q2 2026 | 93.69K | $3.67M | 0.00% | Reduce |
| Norges Bank Investment Management history | Q4 2024 | 129.51K | $2.18M | 0.00% | New |
| Wells Fargo & Co history | Q2 2026 | 54.49K | $2.13M | 0.00% | Add |
| Principal Global Investors history | Q2 2026 | 51.95K | $2.03M | 0.00% | Add |
| Wellington Management Group history | Q2 2026 | 50.86K | $1.99M | 0.00% | Reduce |
| MFS Investment Management history | Q2 2026 | 42.34K | $1.66M | 0.00% | Reduce |
| Citadel Advisors history | Q2 2026 | 41.70K | $1.63M | 0.00% | Reduce |
| JPMorgan Chase & Co history | Q2 2026 | 41.67K | $1.63M | 0.00% | New |
| Citigroup Inc history | Q2 2026 | 32.57K | $1.27M | 0.00% | Add |
| Invesco Ltd history | Q2 2026 | 28.97K | $1.13M | 0.00% | Hold |
| CPP Investments history | Q2 2026 | 18.80K | $735.46K | 0.00% | Reduce |
| Deutsche Bank AG history | Q2 2026 | 17.96K | $702.48K | 0.00% | Add |
| Prudential Financial history | Q2 2026 | 8.63K | $337.53K | 0.00% | Reduce |
| Lazard Asset Management history | Q4 2025 | 5.96K | $255.48K | 0.00% | Reduce |
| Manulife Financial history | Q4 2025 | 5.18K | $221.99K | 0.00% | New |
| Legal & General Investment Management America history | Q2 2026 | 4.13K | $161.53K | 0.00% | Add |
| PNC Financial Services history | Q2 2026 | 27 | $1.06K | 0.00% | Reduce |
| T. Rowe Price Associates history | Q2 2026 | 15.11K | $592 | 0.00% | Add |